Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Completed · Phase 1
Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific
In brief
Phase I trial to study the effectiveness of combining alvocidib, irinotecan hydrochloride, and cisplatin in treating patients who have advanced solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
Key facts
- Study ID
- NCT00046917
- Run by
- National Cancer Institute (NCI)
- People needed
- 13
- Starts
- 2002-07-01
- Last updated by the study team
- 2014-02-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Histologically confirmed locally advanced or metastatic solid tumor that is refractory to standard therapy or for which no standard therapy exists
- Evaluable disease
- No previously untreated CNS metastasis
- No primary CNS tumors
- Performance status - Karnofsky 60-100%
- Performance status - ECOG 0-2
- Not specified
- WBC at least 3,000/mm\^3
- Neutrophil count at least 1,500/mm\^3
- Platelet count at least 100,000/mm\^3
- Bilirubin no greater than 2.0 mg/dL
- AST and ALT no greater than 3 times upper limit of normal (ULN) (5 times ULN if liver metastases are present)
- Creatinine no greater than 1.5 mg/dL
- Creatinine clearance at least 60 mL/min
- No cardiac arrhythmia
- No congestive heart failure
- No myocardial infarction within the past 6 months
- HIV negative
- No neuropathy grade 2 or greater
- No serious or uncontrolled infection
- No other medical condition or reason that would preclude study participation
- Not pregnant or nursing
- Negative pregnancy test
- Fertile patients must use effective contraception during and for at least 2 months after study participation
- At least 4 weeks since prior immunotherapy
Where it is running
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.